SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 86.183
AS - Asia 38.668
EU - Europa 35.689
SA - Sud America 5.971
Continente sconosciuto - Info sul continente non disponibili 2.015
AF - Africa 830
OC - Oceania 218
Totale 169.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 84.109
SG - Singapore 11.677
GB - Regno Unito 10.337
CN - Cina 9.142
IT - Italia 7.701
HK - Hong Kong 5.227
BR - Brasile 4.597
SE - Svezia 4.305
VN - Vietnam 4.211
FI - Finlandia 3.162
DE - Germania 2.488
BD - Bangladesh 2.435
UA - Ucraina 1.602
FR - Francia 1.488
RU - Federazione Russa 1.413
TR - Turchia 1.300
KR - Corea 987
CA - Canada 972
BG - Bulgaria 788
IN - India 695
ID - Indonesia 632
JP - Giappone 572
NL - Olanda 522
AR - Argentina 454
MX - Messico 423
IE - Irlanda 331
IQ - Iraq 327
ES - Italia 249
PK - Pakistan 234
BZ - Belize 230
EC - Ecuador 207
PL - Polonia 204
ZA - Sudafrica 203
AT - Austria 197
AU - Australia 185
AE - Emirati Arabi Uniti 175
CO - Colombia 173
CL - Cile 147
VE - Venezuela 125
EG - Egitto 123
MA - Marocco 119
MY - Malesia 115
CH - Svizzera 112
LT - Lituania 110
PH - Filippine 110
TN - Tunisia 107
SA - Arabia Saudita 93
BE - Belgio 91
PE - Perù 91
CR - Costa Rica 85
CZ - Repubblica Ceca 85
TH - Thailandia 83
HU - Ungheria 80
JM - Giamaica 80
UZ - Uzbekistan 79
PY - Paraguay 74
KE - Kenya 72
DZ - Algeria 66
JO - Giordania 66
TW - Taiwan 60
NP - Nepal 57
PT - Portogallo 56
DK - Danimarca 55
IR - Iran 53
UY - Uruguay 49
AZ - Azerbaigian 47
RO - Romania 45
BO - Bolivia 44
HN - Honduras 44
DO - Repubblica Dominicana 42
GR - Grecia 40
IL - Israele 39
EU - Europa 38
AL - Albania 37
GT - Guatemala 33
RS - Serbia 33
NI - Nicaragua 29
NZ - Nuova Zelanda 28
OM - Oman 26
SN - Senegal 25
BY - Bielorussia 24
KZ - Kazakistan 24
TT - Trinidad e Tobago 23
BH - Bahrain 22
EE - Estonia 22
ET - Etiopia 22
LB - Libano 22
KG - Kirghizistan 21
SV - El Salvador 20
KW - Kuwait 19
PA - Panama 18
PR - Porto Rico 18
LV - Lettonia 17
SY - Repubblica araba siriana 17
NO - Norvegia 16
PS - Palestinian Territory 16
HR - Croazia 15
BB - Barbados 14
SK - Slovacchia (Repubblica Slovacca) 14
KH - Cambogia 13
Totale 167.324
Salva come PNG Salva come JPEG
Città #
Fairfield 8.614
Ashburn 7.807
Singapore 7.214
Santa Clara 7.079
Southend 6.696
Woodbridge 5.939
Hong Kong 5.147
Houston 4.113
Chandler 3.412
Seattle 3.200
San Jose 3.154
Wilmington 2.854
Jacksonville 2.781
Cambridge 2.638
Hefei 2.593
Helsinki 2.558
Ann Arbor 2.339
Council Bluffs 2.310
London 2.243
Dearborn 1.912
Beijing 1.830
Stockholm 1.819
The Dalles 1.412
Modena 1.399
Ho Chi Minh City 1.335
Los Angeles 1.211
Nyköping 1.168
New York 1.143
San Diego 1.010
Hanoi 985
Seoul 908
Milan 853
Chicago 826
Dallas 797
Princeton 780
Sofia 751
Buffalo 711
Lauterbourg 711
Eugene 564
Moscow 550
Columbus 541
Jakarta 449
Izmir 427
Munich 390
São Paulo 387
Shanghai 364
Rome 341
Dublin 293
Bologna 290
Tokyo 282
Salt Lake City 271
Frankfurt am Main 242
Toronto 239
Boardman 237
Atlanta 231
Belize City 229
Orem 216
Las Vegas 201
Redwood City 199
Da Nang 192
Phoenix 175
Haiphong 171
Rio de Janeiro 160
Nuremberg 149
Montreal 143
North Bergen 142
Brooklyn 137
Redondo Beach 137
Mexico City 134
Naples 125
Kent 124
San Francisco 122
Warsaw 119
Miano 118
Boston 117
Florence 116
Stanford 116
Guangzhou 115
Baghdad 112
Parma 111
Amsterdam 110
Norwalk 109
Porto Alegre 109
Reggio Emilia 109
Denver 108
Tampa 106
Elk Grove Village 105
Falls Church 105
Brasília 97
Bremen 97
Johannesburg 97
Nanjing 96
Saint Louis 96
Belo Horizonte 95
Falkenstein 86
Lappeenranta 86
Mumbai 86
Chennai 84
Biên Hòa 83
Ankara 80
Totale 115.974
Salva come PNG Salva come JPEG
Nome #
64 Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells 2.021
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.379
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 523
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria 514
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 506
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 469
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 456
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome 423
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 413
Validation of the classification criteria for cryoglobulinaemic vasculitis 404
Visual loss and other cranial ischaemic complications in giant cell arteritis 379
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 378
Adult Primary Central Nervous System Vasculitis 373
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 371
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 369
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience 357
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 354
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 350
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 349
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 348
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 344
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 343
Clinical features of polymyalgia rheumatica and giant cell arteritis 340
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 336
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 332
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 332
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 330
Acute exacerbation of interstitial lung disease associated with rheumatic disease 330
Retroperitoneal fibrosis 328
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 327
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 324
2018 Update of the EULAR recommendations for the management of large vessel vasculitis 324
Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study 323
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 323
Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? 321
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 319
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 317
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 316
Epidemiology of psoriatic arthritis 316
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 312
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 312
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 312
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 311
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 310
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 308
Polymyalgia rheumatica 307
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 307
A comprehensive review on the role of mesenchymal stromal/stem cells in the management of rheumatoid arthritis 306
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 306
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients 305
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 305
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations 304
Polymyalgia rheumatica 304
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 303
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 303
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 299
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 296
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 295
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 295
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 294
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 291
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 291
Polymyalgia rheumatica and giant-cell arteritis 290
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 290
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 289
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 288
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis 288
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 287
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 286
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 285
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica 284
Unmet Needs in the Pathogenesis and Treatment of Vasculitides 284
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 282
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 282
Anti-drug antibody detection with label-free electrolyte-gated organic field-effect transistors 281
Biotherapies in large vessel vasculitis 280
Comment on: Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature: Reply 279
Imaging of vasculitis: State of the art 279
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 278
EULAR guidelines on ANCA-associated vasculitis in the real life 278
Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients 275
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy 275
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 275
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 275
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 274
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 272
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 272
2018 update of the EULAR recommendations for the management of Behçet's syndrome 272
Trial of Tocilizumab in Giant-Cell Arteritis 271
Management of primary and secondary central nervous system vasculitis 271
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 270
Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study 270
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 270
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 269
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 269
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 268
Giant cell arteritis: Involvement of intracranial arteries 267
Psoriatic disease: concepts and implications 267
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial 267
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 267
Totale 34.463
Salva come PNG Salva come JPEG
Categoria #
all - tutte 698.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 698.057
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212.544 0 1.475 1.334 950 369 965 861 631 1.513 943 2.021 1.482
2022/202310.863 1.386 756 738 798 1.307 1.559 243 1.046 1.697 225 597 511
2023/20248.281 335 532 425 849 1.815 486 515 1.469 246 216 374 1.019
2024/202527.322 1.171 353 400 2.006 4.686 4.221 1.655 1.346 3.413 2.340 2.535 3.196
2025/202653.816 3.024 2.054 4.895 5.202 4.608 4.222 6.900 3.197 6.762 4.095 4.632 4.225
2026/20276.670 2.609 4.061 0 0 0 0 0 0 0 0 0 0
Totale 169.574